Patients suffering from psychiatric disorders have a life span burden, which represents an enormous human, family, social, and economical cost. Several concepts have revolutionized our way of appraising neuropsychiatric disorders (NPDs). They result from a combination of genetic factors and environmental insults, and their etiology finds roots in the neurodevelopmental period.
| INTRODUCTION
The deciphering of the contribution of genetics to the etiology of neuropsychiatric disorders (NPDs) has greatly benefited from genomewide sequence analyses based on next-generation sequencing (NGS) and the constitution of very large cohorts of patients (>80 000). In parallel with this technological breakthrough, our understanding of NPDs has been revolutionized by a number of new concepts.
First, the notion of a continuum between the developing and the adult brain has emerged, based on the discovery that the same molecular components and gene families play crucial roles both during normal neuronal development and in adult brain function. [1] [2] [3] [4] During different time-windows, these genes are required for the proliferation of neural progenitors, neuronal migration, synaptogenesis, and neuronal plasticity. As a consequence, mutations or disturbances in the expression of these genes are associated with NPDs and neuronal dysfunction, even when overt neurodevelopmental defects are absent or not (yet) detectable.
Second, exposure to a wide variety of fetal or perinatal environmental stress increases the risk of developing psychiatric or neurodegenerative disorders in adulthood and reduces the ability of the adult brain to function normally, in line with the Developmental Origins of Health and Disease (DOHaD) concept. [5] [6] [7] Third, recent investigations using epigenome-wide sequence analysis have consolidated the concept that (1) brain development and integrity are finely controlled by epigenetic mechanisms and (2) that alterations of the epigenome have been identified in the brain of patients with various psychiatric diseases and correlated with exposure to prenatal stress. "Epigenetic scars" of perinatal or early-life stress exposure might thus be conserved in the adult brain, in a persistent manner. These molecular signatures could allow earlier diagnosis of NPDs and, based on the reversibility of the epigenetic mechanisms involved, potentially pave the way for future therapeutic strategies.
We will first provide a short overview of recent findings regarding the contribution of genetics to NPDs, and then discuss new findings regarding the impact of the environment on the brain epigenome, obtained using cutting-edge NGS-based technologies, such as epigenome-wide association studies (EWAS).
| HERITABILITY-THE GENOMIC REVOLUTION AND THE GENETIC ARCHITECTURE OF NPDS
Studies in families, twins, or adoption contexts, have underlined the strong influence of genetics in the etiology of schizophrenia (SCZ), autism-spectrum disorder (ASD), as well as attention-deficit hyperactivity disorder (ADHD) and determined that they are the most heritable diseases among genetically complex disorders. [8] [9] [10] However, before the genomic revolution, genetic linkage analyses focusing on families comprising multiple individuals affected by NPDs, have largely failed to uncover genomic segments that would co-segregate with the relevant phenotypes. This is likely due to the high degree of polygenicity of these pathologies (see below).
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The recent contributions of NGS have profoundly modified our vision of human genomic diversity. Single-nucleotide variants (SNVs), copy-number variants (CNVs), as well as short insertions or deletions, compose the complexity of human genome diversity. A typical individual carries differences at 4.1 to 5.0 million sites compared with the reference human genome. 12 Common variants have a minor allele frequency (MAF) comprised between 0.5% and 5%. Rare variants correspond to MAF < 0.5%. Finally, every individual exhibits several tens of variants that are considered as disease-causing mutations, and many more variants that have been found associated with diseases. 13 In this complex landscape, unbiased genome-wide methods have evaluated the "genetic" burden, which is at play in the etiology of NPDs. That is, to which extent single, highly penetrant mutations or, conversely, the combination of numerous low-risk alleles contribute to 1 given NPD.
The success of the genomics revolution in discovering SNVs or CNVs contributing to NPD risk has increased exponentially thanks to the creation of big consortia like the Psychiatric Genomics Consor- We summarize below the main aspects of the very impressive leap forward that has taken place in the field of NPDs. [8] [9] [10] 15 1. The risk of NPDs is highly polygenic and not due to single SNVs or CNVs in most cases. ASD, in which none of the genes identified so far contribute to more than 1% of the cases, is exemplary to this regard. Low-level mosaic aneuploidy has also been reported, especially in the case of ASD. 16, 17 2. The entire spectrum of variants contributes to the genetic burden, "common," "rare," as well as "de novo" SNVs. 4. Correlatively, the cumulation of small effects of numerous genes-rather than strong single-gene effects-has pinpointed common underlying biological pathways. Disruption of synaptic function/plasticity networks seems to be a hallmark of SCZ and ASD, 10, 17, 23, 24 which is partially shared with intellectual disability (ID) and neurodevelopmental disorders (Coffin-Lowry syndrome and Rett syndrome). This includes genes encoding post-synaptic proteins, as well as proteins interacting with these complexes, and also voltage-gated ion channels involved in the action potential, neuronal pacemaking, and excitability-transcription coupling (Table 1 ). In addition, transcriptional regulators and chromatin remodeling factors have also been identified (see below).
| THE ROLE OF EPIGENETIC ACTORS IN THE ETIOLOGY OF NPDS
SCZ, ASD, BPD, ADHD 25 and panic disorders 26 exhibit high levels of heritability. Other psychiatric disorders like MDD display lower heritabilities. 19, [26] [27] [28] In line with a non-Mendelian mode of inheritance, sex differences, and discordance between monozygotic twins are often observed in NPDs. It has been hypothesized that environmental factors could contribute to the etiology of such disorders, 28 perhaps through interactions with genetic variants that need environmental triggers to contribute to the phenotype. 29 Indeed, the appraisal of the interaction between genotype and environment has gained considerable momentum thanks to new NGS approaches that interrogate the epigenome.
| General epigenetic mechanisms
Epigenetics focuses on mechanisms that govern accessibility to genetic information, independently of changes in DNA sequence. The establishment and maintenance of epigenetic profiles are essential for cell lineage determination and differentiation. During these Abbreviations: ADHD, attention deficit hyperactivity disorder; ASD, autism-spectrum disorder; CNV, copy-number variants; DMR, differentially methylated region; DNMT, DNA methyl transferase; FAS, fetal alcohol syndrome; FASD, fetal alcohol spectrum disorders; GWAS, genome-wide association studies; H/KDAC Histone/Lysine deacetylase; H/KMT, histone/lysine methyl transferase; ID, intellectual disabilities; MDD, major depressive disorder; NPD, neuropsychiatric disorder; SCZ, schizophrenia; PAE, prenatal alcohol exposure.
Gene products or pathways that are common to several categories are indicated in bold characters.
processes, cell progenitors, despite the identical genetic information they contain, acquire gene expression patterns that specify different fates. In eukaryotes, a large repertoire of molecules is devoted to the establishment of the epigenetic landscape, and includes sequence- Epigenetic modifications can affect DNA itself ( Figure 1A ). DNA methylation is an important event modulating gene expression, especially by the long-term silencing of transcription. 30 Cytosine residues are methylated by DNA methyltransferases (DNMTs, defined as "writer"
enzymes; Figure 1B ), converting cytosine into 5-methylcytosine (5mC).
DNA methylation is a quintessential process in genome integrity and embryonic development, including brain development. 31 5mC can be sequentially converted into 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and then 5-carboxylcytosine (5caC), thanks to TenEleven translocation enzymes (TET). 31 While 5mC is generally associated with gene silencing, 5hmC is usually associated with the activation of gene expression. This specific modification is strongly present in the brain, with 5hmC levels increasing during neuronal differentiation in the embryonic brain. 32 DNA methylation is detected by specific protein sensors (epigenome "readers") of the methyl-binding protein family (MBP; Figure 1B ). 33 These "readers" are part of larger complexes that comprise histone-modifying enzymes ("writers") and thus modulate DNA accessibility.
In addition to acetylation or deacetylation, histone N-or Cterminal tails undergo various post-translational modifications such as methylation, phosphorylation, ubiquitination or sumoylation ( Figure 1A ). The combination of these reversible modifications defines a "histone code" that allows the broad-ranging control of DNA accessibility. In a similar manner to DNA methylation, there are "writer," "reader" and "eraser" proteins ( Figure 1B) . 34 The acetylation of histones is carried out by lysine/histone acetyltransferases (called KATs or HATs), and facilitates chromatin opening and transcription.
Conversely, histone-deacetylases (HDACs; also called KDACs for lysine deacetylases), remove acetyl groups acting as "eraser" ncRNAs including short (<200 nt) and long RNA molecules (lncRNAs; >200 nt) constitute a further layer of this complex organization, by modifying the recruitment of histone-modifying enzymes or DNMTs. Some of them can also physically act as "sponges" for microRNAs (miRNAs), which regulate the stability of coding RNAs and ncRNAs, or their translatability. 35 
| Epigenetic mechanisms in brain development and their mental health consequences
The dysregulation of epigenetic mechanisms has been associated with cognitive and behavioral defects, as well as NPDs. 3, [36] [37] [38] [39] Recently, a DNA methylome analysis has identified more than 17 new associations of differentially methylated sites with SCZ. 40 Mutations in genes encoding key regulators of chromatin remodeling and gene transcription have been identified in NDPs, through twin and patient cohort studies (mostly de novo mutations, some inherited, SNVs but also CNVs). This is prominent in the case of ASD patients, in which mutations in several epigenetic actors have been also reported (Table 1) , 10, 17, 41 some of which are also found in ID patients (Table 1) . 22 These epigenetic actors act on the chromatin of neuronal precursors or neurons and impact the expression of genes that are implicated in dendritic arborization and spine density, which underlie reduced synaptic and neuronal plasticity, and represent hallmarks of 
| GENOME-WIDE EPIGENETIC INVESTIGATIONS AND INSIGHTS INTO EPIGENETIC CONTRIBUTIONS TO NPDS
The recent explosion of whole genome sequencing has provided increasing evidence that exposure to prenatal or postnatal stress affects the epigenome in a persistent manner and might thus contribute to the emergence of NPDs. This field is only in its infancy, and one should avoid hasty conclusions about the weight of this epigenetic contribution. However, a number of potential avenues for research are worth discussing.
| New tools for exploring the epigenome upon perinatal brain exposure to stress
The advent of NGS has allowed the development of new tools The histone code, coupled with DNA methylation marks, transcription and/or presence of noncoding RNAs, provides information for opening or closing of chromatin conformation, which, globally, controls gene expression. Exploration of the epigenome can be assessed at multiple levels including DNA methylation (Figure 2 ), DNA accessibility in chromatin context, nucleosome and non-histone factor positioning, composition and dynamics of histone marks (Figure 3) . B, Epigenetic writers, readers, and erasers. Several factors contribute to the dynamic regulation of epigenetic landscapes. Epigenetic "writers" (illustrated by "pens") add specific epigenetic marks on chromatin. Methylation of cytosine residues on DNA is performed by DNMTs, whereas methylation or acetylation of amino acid residues, in histone tails, is catalyzed by histone methyltransferases (HMTs) and histone acetyltransferases (HATs), respectively. Epigenetic "erasers," such as histone-deacetylases (HDACs), which deacetylate histones, can remove these marks. Protein sensors ("readers") are able to detect these epigenetic marks (illustrated by magnifying lens). For example, proteins of the methyl-binding family (MBP), such as MeCP2, recognize methylated DNA. "Readers" attract repressor or active complexes, containing chromatin remodelers and thereby control nucleosome density and accessibility to DNA. Altogether, these marks contribute to regulate chromatin accessibility, gene expression, DNA replication and repair. C, Surveying the brain epigenome: a challenging goal. Uses of genome-wide methods to identify epigenetic changes associated with brain disorders faces specific issues. Access to human brain samples is limited and, in most cases, brain tissues are collected post-mortem. Significant correlation between epigenetic modifications found in the brain and those detected in peripheral tissue has been observed and potentially allows the evaluation of neuropsychiatric disorder (NPD) risk and preventive or curative therapy, at the early onset of neurological diseases (see conclusion)
performance 54 A rat model of prenatal famine has revealed altered expression of neurotransmitters, olfactory-associated genes in the prefrontal cortex, and genes associated with synaptic function and transcriptional regulation in the hippocampus of the offspring, with more than 6000 differentially methylated regions (DMRs), and correlative changes in genes controlling the integrity of the plasma membrane. 
| Prenatal alcohol exposure
Ethanol induces a wide range of developmental abnormalities in the CNS at all stages of neurodevelopment: defective proliferation and differentiation of neural precursors, abnormal neuronal migration, neuronal apoptosis, disrupted synaptogenesis, aberrant growth factor signaling and neurotransmission. 56 These defects contribute to a broad spectrum of developmental, emotional, cognition, behavioral and social deficits, referred to as "fetal alcohol spectrum disorder"
(FASD), [57] [58] [59] which affects approximately 1% of births in Western countries. 60 FASD defects range from macroscopic structural abnormalities to subtle neurobehavioral disabilities. 60, 61 In addition, FASD children might share autistic traits. 62 Secondary disabilities also occur, with the marked incidence of MDD and anxiety disorders, as well as vulnerability to addiction. 59, 63 In line with these neuropsychiatric traits, transcriptomic alterations of the GABAergic, glutamatergic, endocannabinoid and retinoic acid pathways occur during neurodevelopment and persist after prenatal alcohol exposure (PAE) in adult animal models. These persistent transcriptional disturbances in the adult are specific to the developmental stage of exposure, falling into non-redundant gene ontology (GO) categories. PAE notably perturbs transcriptional programs that are active at the time of exposure: cell death and proliferation during the equivalent of the first trimester of pregnancy in humans, cell migration and differentiation for the second, and cellular communication and neurotransmission for the third one, all of which may impact on the number of neurons, axon development, or synaptic function. [64] [65] [66] [67] [68] Differential DNA methylomic profiles are among the most studied epigenetic marks in PAE studies, including ex vivo cell systems or mouse models of chronic voluntary or binge-like drinking by pregnant mothers, or FASD patients. Several thousands of DMRs have been found in these studies involving different methylomic approaches (Figure 2 ; Table 1 ). In murine models, DNA methylation was altered for more than 6000 promoters. Pathways that regulate neurodevelopmental processes, such as morphogenesis, synaptogenesis and synaptic plasticity, were overrepresented among these DMRs. 67, 69 In a binge-drinking PAE paradigm, Kleiber et al 66, 67 identified DMRs coupled with altered expression regardless of timing of exposure, among which genes encoding glutamate receptor subunits and neurotrophic molecules appear to be central ( as the SNRPN-UBE3A locus, which are also found in mouse PAE paradigms. 66, 67 Notably, the latter corresponds to a locus important for neurodevelopment and brain performance 74 and also genetically affected in ASD patients. 10, 41 The most significant canonical pathways involved govern synaptic plasticity, with prominent DMRs associated to genes involved in glutamatergic transmission and Hippo signaling ( Table 1 ). All these pathways are implicated in several NPDs displaying endophenotypes similar to FASD, such as ASDs, BPD and SCZ. 62, 75 Other epigenetic actors affecting histone methylation 76, 77 and miRNAs 68, 78, 79 are also at play in the short-and long-term consequences of PAE.
| Maternal and early-life stress and the epigenetic component of psychiatric disorders
The impact of maternal stress on the epigenome of the offspring and its vulnerability to NPDs
Maternal exposure to stress during pregnancy (elevated anxiety) and unmedicated maternal depression represent recognized risks for the development of emotional, affective, and anxiety disorders, cognitive defects, and MDD, SCZ, or ASDs, in the offspring. 80, 81 The major "suspect" is elevated maternal blood cortisol concentrations due to adverse emotional states during pregnancy. This bears negative consequences for the offspring regarding the regulation of the hypothalamo-pituitary axis (HPA), the development of brain structures involved in the processing of emotional signals and cognitive performance, and neurodevelopmental processes, including synaptogenesis and neuronal plasticity (Table 1) . 50 Seminal studies have unraveled the occurrence of SCZ in the offspring of women following the 5-day invasion and defeat of the Netherlands in May 1940. 82 Recently, the Avon Longitudinal Study of Parents and Children (ALSPAC) and the "Project Ice Storm"-a study conducted following a series of freezing rain storms that affected more than 3 million people in 1998 in Quebec (Canada) 83 demonstrated a significant association between maternal stress and psychotic experiences, 84 cognitive and linguistic disabilities, 85 autistic traits, 86 as well as the implication of the immune and inflammatory pathways in offspring. 87, 88 Studies in rodents suggest a causal relationship between maternal stress and the modification of DNA methylation in several "candidate genes" in the brain, of importance for HPA integrity and behavioral stress responsiveness, with correlative gene misexpression (Table 1) . 89 In humans, elevated maternal cortisol and anxiety levels during pregnancy have been found to be associated with DNA meth- (Table 1) . 44, 90 Perturbations in DMRs associated with immune function were confirmed by a study showing association with history of maternal depression and a significant overlap of DNA methylation changes between cord blood T cells at birth and adult hippocampi. 47 Dysregulated expression of genes involved in the immune function could, for example, affect the microglia status, the immune component of the brain, which controls brain function.
Early-life stress, brain development, and increased risk of
MDD, affective and anxiety disorders
Mothering behavior (high vs low maternal care), parental bonding (quality of the attachment, sensitivity to infant cues), parental absence (institutional rearing), neglect or abusive caregiving (sexual abuse or assault, familial hostility, socioeconomic conditions) all have profound effects on the cognitive trajectory and the ability to cope with stress (resilience vs psychopathology). These early-life stress also influence the risk of developing SCZ, ASD, and affective disorders. 102 The data based on human cohorts have been strengthened by large-scale data in monkeys. 43 Changes in DNA hydroxymethylation upon early-life stress have also been shown FIGURE 2 Exploring the DNA methylome. DNA methylation has been the most studied epigenetic mark, so far. A, Bisulfite conversion. Methylated and unmethylated cytosines can be distinguished from one another using sodium bisulfite treatment. Sodium bisulfite converts unmethylated DNA into uracile (which is then converted to thymidine after polymerase chain reaction [PCR]), but does not affect hydroxymethylated, nor methylated cytosines. (B and C) Exploration of the DNA methylome relies on 2 alternative strategies: methods that utilize bisulfite conversion (B) or methods that take advantage of recognition of the methyl group by antibodies or methyl-binding proteins (C). B, Mapping methylated cytosines. After DNA fragmentation and bisulfite conversion, DNA methylation can be analyzed genome-widely on a single nucleotide level by whole-genome bisulfite sequencing (WGBS). This technique is highly expensive, requires high depth and heavy bioinformatics and biostatistics analyses, and is thus comparatively poorly informative. Alternative strategies are based on enrichment in regions of interest for the investigation of DNA methylation. Reduced representation bisulfite sequencing (RRBS) takes advantage of MspI restriction enzyme, which recognizes the consensus 5'CCGG3' sequence and cuts it upstream of the CpG dinucleotide. Each fragment of the digested DNA therefore possesses a CpG at each end. Other strategies are based on enrichment in a limited number of regions of interest (containing CpGs) by hybridization with specific probes either on "arrays" that can quantitatively interrogate over 450 000 to 850 000 methylation sites, covering 96% of CpG islands plus (or not) CpGs outside of CpG islands (HumanMethylation450K vs 850K array, Illumina technology) or Capture (Roche NimbleGen technology; up to 5.5 M CpGs). HumanMethylation arrays use 2 types of beads: "M" beads that trap sequences containing methylated C and "U" beads that trap sequences converted by bisulfite treatment. Roche NimbleGen Capture uses beads containing customized probes that correspond to all the converted and non-converted versions of selected sequences. In any case, prior to sequencing, the fragmented DNA is linked to sequence adapters (yellow rectangles) to allow library construction and amplification. The reads are then aligned on reference genome using specific software. C, Precipitation of methylated DNA (methylated DNA immunoprecipitation [MeDIP] ). Enrichment for methylated DNA sequences can also be performed at a genome-wide scale by isolating methylated DNA fragments by immunoprecipitation using an antibody recognizing 5-methylcytosine (5mC). Isolated regions can be then processed for next-generation sequencing (NGS) or hybridization to "arrays." Similar hMeDIP explores the hydroxymethylome, using an antibody raised against 5-hydroxymethylcytosine (5hmC). Methylated-CpG island recovery assay (MIRA). Alternatively, methylated DNA sequences can be precipitated and isolated, using the high affinity of the (GST-bound) MBD2b/MBD3L1 protein complex for methylated DNA. [110] [111] [112] to occur within promoters of genes related to neurological functions and psychological disorders. 103 
| Gene × environment/epigenetics
The idea underpinning "gene × environment" paradigm is that the same genetic variant might contribute to the risk of developing different NPDs, and that its effects would be modulated in both prenatal and postnatal periods through epigenetic changes in response to physiological or adverse environmental conditions. For example, besides the combinatory actions of genetic and environmental fac- ter stratification in any given NPD. As such, a recent study has brought convincing evidence that epigenetic data might be even more informative than genetic data in predicting for all-cause mortality. 48 
| CONCLUSIONS
While large-scale genomics has unveiled the genetic architecture of NPDs, investigations of psychiatric genetic architecture is yet not in the post-genetic phase, and a lot remains to be unraveled. Epigenetics could contribute to the etiology of these lifelong diseases. In particular, with the undertaking of new research including very large cohorts and a careful assessment of genomic status, epigenomic studies could reveal an unknown history of exposure to prenatal or postnatal adverse conditions. They could thus explain how stress increases the risk of developing NPDs, provide early markers for diagnosis, and lead to improved follow-up and outcome in patients.
Because epigenetic events are potentially reversible, the early diagnosis of NPDs is key to these advances, because windows of opportunity, in which the plasticity of the epigenome might be more pronounced, do exist.
The field of epigenomics is still limited by a number of factors that can, however, be largely circumvented. Compared with the power of genetic studies, the size of cohorts for epigenomic investigations has been limited, underlining the necessity of developing new consortia to increase the number of healthy individuals and patients, along the model of the BrainSeq Consortium, for example. 106 The influence of confounding variables is intrinsic to studies based on environmental adversities and includes genetic factors, socioeconomic status, nutrition, or coexposure to other substances (smoking, psychotropes, toxins…). An accurate measurement of the dosage and mode of exposure (acute, chronic…) to the substance of interest is also often difficult. Efforts must be sustained to continue taking these aspects into account and apply them to larger cohorts.
Sexual dimorphism in NPD patients (and animal models; Figure 1 ) has been reported and is also observable for DNA methylation changes, 50 but remains understudied. Age (chronological/natural vs pathological aging) and disease severity should also be taken into account. 48, 107 Access to post-mortem brain tissues from NPD patients is another confounding issue, because of the lack of appropriate con- Schematic summary of the action of epigenetic mechanisms in the etiology of neuropsychiatric disorders (NPDs). Nature, severity, duration of stress, and stage of exposure in the developing brain could modulate in a fine-tuned manner the induced disturbances of the epigenome and result in brain abnormalities, some of which, being common to several NPDs, whereas others being specific of one given NPD abnormal mobilization in response to stress could account for the etiology of NPDs is still controversial. 
